Target & Activity
| Target | Activity | Value |
|---|---|---|
| PI3Kα | IC50 | 33 nM |
| PI3Kα-H1047R | IC50 | 36 nM |
| PI3Kα-E542K | IC50 | 63 nM |
| PI3Kα-E545K | IC50 | 136 nM |
| PI3Kδ | IC50 | 451 nM |
| PI3Kβ | IC50 | 661 nM |
| PI3Kγ | IC50 | 708 nM |
| Vps34 | IC50 | 6486 nM |
| mTOR | IC50 | 89 nM |
| mTORC1 | ||
| mTORC2 | ||
| DNA-PK | IC50 | 8567 nM |
12 targets · Scroll to view more
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A2058 | IC50 | 139 nM | Inhibition of mTORC2 in human A2058 cells assessed as reduction in PKB phosphorylation at S473 residues incubated for 1 hr by Western blot analysis | [PMID: 31465220] |
| A2058 | IC50 | 139 nM | Inhibition of Class 1 PI3K/mTOR in human A2058 cells assessed as reduction in Akt phosphorylation at Ser473 residue incubated for 1 hr by InCell Western assay | [PMID: 31244112] |
| A2058 | IC50 | 205 nM | Inhibition of mTORC1 in human A2058 cells assessed as reduction in ribosomal protein S6 phosphorylation at Ser235/236 residues incubated for 1 hr by Western blot analysis | [PMID: 31465220] |
| A2058 | IC50 | 205 nM | Inhibition of Class 1 PI3K/mTOR in human A2058 cells assessed as reduction in S6 phosphorylation at Ser235/236 residue incubated for 1 hr by InCell Western assay | [PMID: 31244112] |
| A2058 | IC50 | 2333 nM | Antiproliferative activity against human A2058 cells after 48 hrs by sulforhodamine B assay | [PMID: 28829592] |
| SK-OV-3 | IC50 | 237 nM | Antiproliferative activity against human SKOV3 cells after 48 hrs by sulforhodamine B assay | [PMID: 28829592] |